ACHN stock forecast
Our latest prediction for Achillion Pharmaceuticals, Inc.'s stock price was made on the Nov. 20, 2017 when the stock price was at 3.45$.
In the short term (2weeks), ACHN's stock price should underperform the market by -0.49%. During that period the price should oscillate between -10.17% and +14.14%.
In the medium term (3months), ACHN's stock price should outperform the market by 3.96%. During that period the price should oscillate between -20.83% and +37.58%.Get email alerts
About Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.56$ per share.
The book value per share is 2.13$
Three months stock forecastNov. 20, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|